Guizhou Bailing Group Pharmaceutical Co., Ltd. (SZSE:002424) announces a share repurchase program. Under the program, the company will repurchase up to 16,260,000 A shares, representing 1.15% of its issued share capital, for total worth of CNY 200 million. The shares will be repurchased at a price of CNY 12.30 per share. The purpose of the share repurchases is for implementation of equity incentives or employee stock ownership plan. The share repurchases will be funded from company's own funds. The program is valid for 6 months.